- Telehealth Visits
Lillian Swiersz, MD
- Telehealth Visits
Lillian Swiersz, MD
- Telehealth Visits
On this page
About me
This provider works with UCSF through an arrangement with UCSF Benioff Children's Physicians (UBCP), a multispecialty physician foundation connecting physicians and group practices throughout the greater Bay Area.
Education & training
Board certification
- Reproductive Endo/Infertility, American Board of Internal Medicine
- Obstetrics & Gynecology, American Board of Obstetrics and Gynecology
Fellowship
- Reproductive Endocrinology & Infertility, Stanford University School of Medicine
Residency
- Obstetrics & Gynecology, Kaiser Foundation Hospital GME-Oakland
Internship
- Obstetrics & Gynecology, Kaiser Foundation Hospital GME-Oakland
Degree
- MD, Stritch School of Medicine and Dentistry
Component Name: Provider Research Listing component built but no clinical trials or publications to display
Clinical Trials query: q=health_gateway_id_ss%3A%28%221235%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%221235%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.